Navigation Links
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, October 25, 2007
Date:10/5/2007

WALTHAM, Mass., Oct. 5 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it will release its financial results for the third quarter of 2007 before the market opens on Thursday, October 25, 2007, and will hold a conference call on the same day at 9:00 a.m. Eastern time.

During the call, the company will discuss its third quarter financial performance as well as future expectations. To listen, call 866-802-4321 within the U.S. or 703-639-1318 outside the U.S. and use conference ID 1026519. Please begin dialing at least 10 minutes before the scheduled starting time. You may also listen to the call live on our Website, http://www.thermofisher.com, by clicking on "Investors." The earnings press release and related information will be in the Investors section under "Quarterly Results." An audio archive of the call will be available in the "Webcasts and Presentations" section through Friday, November 23, 2007.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industria
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Normalizing cDNA libraries using the EppendorfThermomixer
2. Rapid PCR* Using Active Tube Temperature Control On Thermos PCR Machines
3. A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase
4. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
5. UW-Madisons Beebe wins scientific award
6. Researchers say scientific reporting needs more perspective, less hype
7. Wisconsin stands at the center of scientific efforts to avert flu epidemics
8. Growth prompts new location for scientific instrument manufacturer
9. UW stem cell guru outlines scientific and political future
10. Wisconsin biotech sector featured in scientific magazine
11. Scientific Protein Laboratories Acquired by New York firm

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...EN,Italy,November24/PRNewswire/--HealthRoboticstod...ewithagroupofselected,investors.Thisrecentlyformed...RoboticsCanada,Inc.andwillmarket,install,andsuppor...ncludesthe,revolutionaryproductofferingsi.v.STATIO...aInc.willalsoprovideassistanceonan"asneeded,basis"...
(Date:11/24/2009)...TTLE,Nov.24/PRNewswire-FirstCall/--CellTherapeutic...tatthe21stAnnualPiperJaffrayHealthCareConference.T...kPalaceHotel. ,, CTIwillpresentonTuesday,Decemb...audiowebcastofCTI,spresentationwillbeavailableat w...orreplayafterwards. , ,PiperJaffrayHealthCareConf...
(Date:11/23/2009)...omputing promises ultra-fast communication, comput...information. But trying to use quantum states as c...siness. Now two physicists have shown, mathematica...ntum communication, while keeping the information ...e of Physical Review Letters and highlighted wit...
(Date:11/23/2009)...SISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioScie...ctdevelopmentcompanythatidentifiesandadvancesadive...iousstagesofdevelopment,todayreportedthatCytopia(A...uatingCYT387,apotent,orally-administeredJAK1/JAK2i...hester,Minnesota.AproposaltomergeCytopiaintoYMhasb...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...e profiling of protein biomarkers in tissue now, ...utions through Brigham and Women,... 29 HistoRx, Inc., announced today,that the patho... (BWH) will,begin making the company,s AQUA(R) tec...to the more than 900 Dana-Farber/Harvard Cancer Ce...
...atic, or fully differentiated, human cells back to...any of the significant scientific and social chall...help realize the promise of regenerative medicine....monstrated that such a transformation (reprogrammi...nefficient and, when it does work, poorly understo...
..., Inc. (Nasdaq:,SQNM) today announced that a live ...will be provided for its analyst and investor brie...enatal Diagnostics." Details of the,event are as f...nvasive Prenatal Diagnostics, When: Tuesday, ... http://www.sequenom.com , Agenda: Hosted by:...
Other Biology Technology:HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center 2HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center 3New insights into cellular reprogramming revealed by genomic analysis 2Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3 2
(Date:11/25/2009)...e heart pumps some 250 million liters of blood thr... fibers of the heart have to be extremely durable....er, vice chair of the Department of Medicine III a...Dr. H. A. Katus), has discovered a protein that is...cular unit, the sarcomere. In cooperation with oth...
(Date:11/25/2009)... just as vital to your health as what you eat, fou...l Studies. Their experiments in mice revealed that... in the liverthe body,s metabolic clearinghouseis ...dy,s circadian clock as conventional wisdom had it... a large number of genes completely independent of...
(Date:11/24/2009)...) today named 12 new grant recipients for 2009. Th...ive work across a broad spectrum of lupus research... and potential to drive scientific discovery to ul...ase of systemic lupus. , The 2009 grants go to b...he nation and include interdisciplinary and highly...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Tyco International to Present at the Citi Industrial Manufacturing 26amp 3B Transportation Conference 60962 1Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 14768 1Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 14768 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 14768 3Pharma and Biotech Leaders to Converge in Shanghai 14765 1Pharma and Biotech Leaders to Converge in Shanghai 14765 2
...ow highlight research in the ESA journals Frontie...ological Applications and Ecological Monographs ... wildfire severity but may invite invasives , ...compares the effectiveness of fire fuel reduction ...ogate Study. Four articles examine the effects of ...
.... Prenatal exposure to an insecticide commonly us...ty epidemic in women, according to a new study inv...rs. , More than 250 mothers who live along and ea...xposure to DDE a breakdown of DDT. The study, pub...on of Occupational and Environmental Medicine , a...
...as a moon named Deimos, so it seems only appropria... have its own DEIMOS. This DEIMOS, however, is an ...vements of fish and zooplankton. , MARS, which st...sists of a node the size of two compact cars that ...rnet connection for scientific instruments. Connec...
Other Biology News:Highlights from the March editions of ESA journals 2Highlights from the March editions of ESA journals 3Exposure to insecticide may play role in obesity epidemic among some women 2DEIMOS joins MARS and its satellite of instruments on seafloor 2DEIMOS joins MARS and its satellite of instruments on seafloor 3
QuantiChrom Zinc Assay Kit from BioAssay Systems
Mouse Anti-Human PDGF R beta Monoclonal Antibody, Unconjugated, Clone PR7212 from R&D Systems
Mouse IL-23, Unconjugated from R&D Systems
Rabbit Serum from Lifeblood Medical, Inc.
Biology Products: